Image Source: India Today
India’s cinema halls are facing a new box office villain—and it’s not a blockbuster. The rise of OTT platforms has fundamentally altered how audiences consume content, leading to a decline in theatrical footfalls and a growing preference for streaming. Despite a few theatrical hits, the industry is grappling with shorter theatrical runs, rising production costs, and a public increasingly saying, “We’ll wait for the OTT release.”
What’s Driving the Shift?
-
Convenience Wins: With over 547 million OTT users in India, platforms like Netflix, Prime Video, and JioCinema offer instant access to content—no queues, no ₹300 tickets, no commute.
-
High Costs, Low Returns: Big-budget films like Housefull 5 and Sky Force failed to recover costs despite star power, while mid-budget films are increasingly skipping theatres altogether.
-
Digital Rights First: Many producers now pre-sell digital rights to OTT platforms to recover investments before theatrical release, reducing the pressure to perform at the box office.
-
Pandemic Habits Persist: The COVID-19 era normalized home viewing, and audiences have grown accustomed to watching new releases from their couches.
-
Content Saturation: With a flood of content available online, viewers are more selective about what’s “theatre-worthy.”
The Industry’s Counterpunch
-
Exclusive Theatrical Releases: Aamir Khan’s Sitaare Zameen Par is being released only in theatres—a bold move applauded by the Multiplex Association of India3.
-
Re-releases & Nostalgia: Theatres are bringing back classics like Rockstar and Jab We Met to draw in crowds at lower ticket prices.
-
Collaborative Risk-Sharing: Producers are teaming up to co-finance films and minimize losses, often greenlighting projects only after securing OTT deals.
What the Experts Say
“OTT has changed the game. Unless the content is compelling and cinematic, audiences are happy to wait,” says film trade analyst Girish Wankhede.
“Theatres need to offer more than just a screen—they need to offer an experience,” adds writer Niren Bhatt.
Sources: Rediff, Hindustan Times, India Today
Advertisement
Advertisement